Amwill Health — 360° view

Amwill Health, a company in the Pharmaceuticals industry, reported revenue of ₹23 crore and net profit of ₹4.00 crore for the September 2026 quarter.

Amwill Health (BSE: AMWILL) closed at ₹43.00 on 20 Nov 2026, down 9.3% over the past year. Its market capitalisation is ₹86 crore and it trades at 7.7 times earnings.

Share price
₹43.00 (20 Nov 2026)
Market cap
₹86 Cr (20 Nov 2026)
P/E
7.66 (20 Nov 2026)
Revenue
₹23 Cr (September 2026 quarter)
Net profit
₹4 Cr (September 2026 quarter)
ROCE
20.5% (FY26)
ROE
15.3% (FY26)
Book value
₹41.6 (FY26)
Dividend yield
1.20% (FY26)
52-week high / low
₹50.90 / ₹28.91 (20 Nov 2026)
1-year return
-9.3% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: AMWILL

Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.